John Adams

CEO and President

Canadian PKU & Allied Disorders

John Adams is a seasoned management consultant with a current focus on advocacy for unmet patient health needs. He has extensive experience in public policy, governance and senior management. A frequent author and commentator on health-related public issues, he is a senior fellow at the Macdonald-Laurier Institute.
John is co-founder, CEO and President of a Canadian non-profit (CanPKU) and a founding trustee and board chair of a global charity, the Global Association for PKU (GAP).  Their missions are to improve the lives of people living with PKU and their families. John is a published author and lay expert in the modern miracle of screening newborns for rare inherited conditions to achieve early diagnosis and early interventions for best possible outcomes.

All Sessions by John Adams

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

2:00 pm

2:00 pm



Canada ranks 10th out of 14 countries on its attractiveness for new medicine launch according to PDCI’s 2022 Biopharmaceutical Ecosystem Index. To ensure Canadian patients gain access to the new medicines of the future, we must keep pace with how constantly evolving local and international market access landscapes will affect Canada’s relative attractiveness for launch in the years to come. Develop your advocacy plan by:

  • Learning how Canada currently stacks up on its Development & Commercialization Infrastructure, Regulatory Landscape, and Market Access Environment
  • Identifying the policy areas that could most effectively improve our relative attractiveness
  • Discussing what Canada’s attractiveness rankings mean to Canadian patients

Share perspectives with your senior management that can help make a difference in future new drug launches

Agenda: Day 2 Oct 6, 2020